Related Experiment Video
Updated: Jun 29, 2025
09:44
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
147
Synthetic neuroactive steroids
Štefan Alušík1, Zoltán Paluch2,3,4, Dagmar Kalátová2
1Department of Internal Medicine, Institute for Postgraduate Medical Education, Prague, Czech Republic.
Neuro Endocrinology Letters
|April 7, 2024
Summary
Synthetic neuroactive steroids offer significant therapeutic potential for neurological and psychiatric disorders. Further research and clinical trials are needed to fully utilize these compounds beyond current applications.
Area of Science:
- Neuroscience
- Pharmacology
- Medicinal Chemistry
Background:
- Neuroactive steroids modulate neuronal excitability and function.
- Previous synthetic neuroactive steroids faced market withdrawal due to various reasons.
Purpose of the Study:
- To review synthetic neuroactive steroids, including their mechanism of action.
- To examine approved and investigational synthetic neuroactive steroids.
- To discuss their clinical applications, efficacy, and adverse effects.
Main Methods:
- Literature review of synthetic neuroactive steroids.
- Analysis of clinical trial data for selected compounds.
- Examination of approved drug information and withdrawal reasons.
Main Results:
- Overview of established synthetic neuroactive steroids and reasons for discontinuation.
- Detailed examination of 6 specific synthetic neuroactive steroids in clinical trials or approved.
- Identification of indications, clinical experience, and adverse effects for these agents.
Conclusions:
- The full therapeutic potential of synthetic neuroactive steroids remains largely untapped.
- Wider application in neurological and psychiatric disorders is anticipated.
- Further investigation is warranted to expand their clinical utility.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
01:23Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
01:25Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
01:26Neurochemical Transmission: Sites of Drug Action
2.3K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.3K
01:27Adrenergic Neurons: Neurotransmission
3.7K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.7K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K